News

Promoting generics prescribing in the UK

Published on 2015/02/12

Possible ways to encourage more prescribing of generics in the UK include financial incentives with educational intervention and audit/feedback, according to a review of data on prescribing behaviou...

1 views

Read more →

WHO calls for better science-based regulations for biosimilars

Published on 2015/02/10

The sixty-seventh World Health Assembly (WHA) of the World Health Organization (WHO) closed on 24 May 2014, after adopting more than 20 resolutions on public health issues of global importance, one ...

1 views

Read more →

Patients’ perception of generics in the Philippines

Published on 2015/02/06

A survey of patients in the Philippines showed that less than half were offered a generic drug alternative and even fewer asked for a generic drug alternative. The survey also revealed that patients...

2 views

Read more →

ABPI issues updated position paper on biosimilars

Published on 2015/02/04

On 14 May 2014, the association that represents innovative research-based biopharmaceutical companies in the UK, the Association of the British Pharmaceutical Industry (ABPI), issued the third editi...

1 views

Read more →

Generic atypical antipsychotic drugs in Belgium

Published on 2015/02/02

Health authorities are continually looking to increase the utilization of low cost generics to save considerable monies without compromising care, given the ever increasing pressure on available res...

1 views

Read more →

Physicians’ views on generics in the Philippines

Published on 2015/01/30

A survey of physicians in the Philippines has revealed that five out of six drugs are prescribed using generic names, with physicians in the public sector prescribing generics significantly more oft...

1 views

Read more →

Impact of delisting ARBs in Denmark

Published on 2015/01/28

Health authorities are looking to increase the utilization of low cost generics to save considerable resources without compromising care. This includes Denmark [1]. Patent-protected angiotens...

4 views

Read more →

Pharmacists’ attitudes towards generics in Czech Republic

Published on 2015/01/26

A study carried out in the Czech Republic found that whether pharmacists routinely carried out generics substitution depended on their familiarity with the relevant legislation and their attitude to...

2 views

Read more →

Biosimilar epoetin shows good safety profile in post-authorization study

Published on 2015/01/22

US-based generics manufacturer Hospira announced on 28 April 2014 positive results from a post-authorization observational safety study of its biosimilar epoetin product Retacrit/Silapo (epoetin zet...

1 views

Read more →

FDA releases further biosimilars guidance

Published on 2015/01/20

The US Food and Drug Administration (FDA) has issued new draft guidance for biosimilars. The draft guideline, issued in May 2014, explains how to use clinical pharmacology data to show biosimilarity...

1 views

Read more →

The Brazilian generics market

Published on 2015/01/16

Generics are an effective tool to provide affordable, safe and reliable medicines to patients in Brazil, according to a presentation by Telma Salles [1]. Brazil is big. A population of 186 mi...

1 views

Read more →

Biosimilar trastuzumab candidates in phase III development

Published on 2015/01/14

The introduction of Herceptin (trastuzumab) revolutionalized the treatment of breast cancer. Prior to its introduction there were few treatment options available to women with human epidermal growth...

4 views

Read more →